Easwaran Sreekumar
VIDWAN ID: 63760

Dr Easwaran Sreekumar

Male Doctor of Philosophy
Scientist E2
Rajiv Gandhi Centre for Biotechnology
Kerala
Expertise: Biotechnology and Applied Microbiology
18 Publications
0 Projects
26 Scopus Citations
94 CrossRef
19 Years 3 Months Total Experience
Publications
18 Total
Articles
18
Activity

No publication activity to display.

Scopus Scopus
26 Citations
3 h-index
CrossRef CrossRef
94 Citations
6 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Personal Details

Doctor of Philosophy
2004
Defence Institute of Advanced Technology, Girinagar, Pune
Scientist E2
Jun 2007 – Present
Rajiv Gandhi Centre for Biotechnology
Medical and Health Sciences
Biotechnology and Applied Microbiology

Related Profiles

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Reproducible generation of Nipah virus pseudovirions with uniform incorporation of F and G surface glycoproteins for high-throughput neutralization assays

Open Access
Journal Article
BMC Microbiology. Year: 2025. Volume: 25 , Issue: 1 .
Authors: Geetu Rose Varghese; Vivek Vijay; Sreeja Sreedevi; Santhik S. Lupitha; Priya Prabhakaran; Sushama Aswathyraj; Anitha P. Moorkoth; Niyas K. Pulloor; Easwaran Sreekumar

Genetic analysis of the SH gene of mumps virus genotype C in Kerala during 2024–25

Journal Article
Year: 2026. Volume: 62 , Issue: 3 , Pages: 297-307 .
Authors: Rajendra Kumar; Minju Sara Simon; B. Aneesh; P. S. Chippy; Arun V. Jose; Amogh Auti; D. J. Hima; S. Aswathyraj; E. Sreekumar

Fingolimod (FTY720), an FDA‐approved sphingosine 1‐phosphate (S1P) receptor agonist, restores endothelial hyperpermeability in cellular and animal models of dengue virus serotype 2 infection

Open Access
Journal Article
IUBMB LIFE. Year: 2024. Volume: 76 , Issue: 5 , Pages: 267-285 .
Authors: Ayan Modak; Srishti Rajkumar Mishra; Mansi Awasthi; Arya Aravind; Sneha Singh; Easwaran Sreekumar

Nucleophosmin (NPM1)/B23 in the Proteome of Human Astrocytic Cells Restricts Chikungunya Virus Replication

Journal Article
Journal of Proteome Research. Year: 2017. Volume: 16 , Issue: 11 , Pages: 4144-4155 .
Authors: Rachy Abraham; Sneha Singh; Sreeja R. Nair; Neha Vijay Hulyalkar; Arun Surendran; Abdul Jaleel; Easwaran Sreekumar

Targeting cap-dependent translation to inhibit Chikungunya virus replication: selectivity of p38 MAPK inhibitors to virus-infected cells due to autophagy-mediated down regulation of phospho-ERK

Journal Article
Journal of General Virology. Year: 2021. Volume: 102 , Issue: 7 .
Authors: Prashant Mudaliar; Parvanendhu Pradeep; Rachy Abraham; Easwaran Sreekumar

Generation of a Live-Attenuated Strain of Chikungunya Virus from an Indian Isolate for Vaccine Development

Open Access
Journal Article
Vaccines. Year: 2022. Volume: 10 , Issue: 11 , Pages: 1939 .
Authors: Sreeja R. Nair; Rachy Abraham; Easwaran Sreekumar

Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine

Journal Article
Journal of Ethnopharmacology. Year: 2023. Volume: 309 , Pages: 116366 .
Authors: A. Sagna; Reshma V.R. Nair; Neha Hulyalkar; S. Rajasekharan; Vinodkumar T.G. Nair; K.C. Sivakumar; S.R. Suja; Sabulal Baby; Easwaran Sreekumar

Higher‐temperature‐adapted dengue virus serotype 2 strain exhibits enhanced virulence in AG129 mouse model

Journal Article
The FASEB Journal. Year: 2023. Volume: 37 , Issue: 8 , Pages: e23062 .
Authors: Ayan Modak; Srishti Rajkumar Mishra; Mansi Awasthi; Sreeja Sreedevi; Archana Sobha; Arya Aravind; Krithiga Kuppusamy; Easwaran Sreekumar
Showing 1 to 8 of 18 publications